Author:
Desnoyers L R,Pai R,Ferrando R E,Hötzel K,Le T,Ross J,Carano R,D'Souza A,Qing J,Mohtashemi I,Ashkenazi A,French D M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference46 articles.
1. Anthony PP . (1979). Precancerous changes in the human liver. J Toxicol Environ Health 5: 301–313.
2. Bange J, Prechtl D, Cheburkin Y, Specht K, Harbeck N, Schmitt M et al. (2002). Cancer progression and tumor cell motility are associated with the fgfr4 arg(388) allele. Cancer Res 62: 840–847.
3. Cappellen D, De Oliveira C, Ricol D, de Medina S, Bourdin J, Sastre-Garau X et al. (1999). Frequent activating mutations of fgfr3 in human bladder and cervix carcinomas. Nat Genet 23: 18–20.
4. Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA et al. (2001). Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. Blood 97: 729–736.
5. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM et al. (1997). Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16: 260–264.
Cited by
219 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献